0000950170-24-084297.txt : 20240717
0000950170-24-084297.hdr.sgml : 20240717
20240717163011
ACCESSION NUMBER: 0000950170-24-084297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hassanein Waleed H
CENTRAL INDEX KEY: 0001430466
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 241122579
MAIL ADDRESS:
STREET 1: TRANSMEDICS INC
STREET 2: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
ownership.xml
4
X0508
4
2024-07-15
0001756262
TransMedics Group, Inc.
TMDX
0001430466
Hassanein Waleed H
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
true
true
false
false
President & CEO
true
Common Stock
2024-07-15
4
M
false
8625
13.28
A
70268
D
Common Stock
2024-07-15
4
S
false
1397
143.61
D
68871
D
Common Stock
2024-07-15
4
S
false
2540
144.34
D
66331
D
Common Stock
2024-07-15
4
S
false
2046
145.54
D
64285
D
Common Stock
2024-07-15
4
S
false
2342
146.39
D
61943
D
Common Stock
2024-07-15
4
S
false
300
147.28
D
61643
D
Common Stock
469359
I
By the Waleed H. Hassanein Revocable Trust
Stock Option (Right to Buy)
13.28
2024-07-15
4
M
false
8625
0
D
2032-02-22
Common Stock
8625
122125
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $143.00 to $143.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $144.03 to $144.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $145.07 to $145.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $146.00 to $146.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $147.02 to $147.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
By: /s/ Stephen Gordon, Attorney-in-Fact
2024-07-17